论文部分内容阅读
目的:采用低分子肝素对羊水过少进行治疗,探究疗效以及临床应用适应性。方法:选择我院中2016年1月至2017年2月中收治的患有羊水过少的妊娠期患者100例作为研究对象,按照妊娠期患者的入院顺序将其分为对照组以及实验组,每组中包含50例妊娠期患者。对照组患者根据病症的发展情况和患者体质应用葡萄糖滴注进行常规治疗;实验组患者在对照组的治疗基础上联合低分子肝素进行治疗,对两组患者的治疗效果进行记录并对比。结果:实验组患者的治愈率明显高于对照组,并且实验组患者的羊水指数、脐动脉血流阻力、数据明显优于对照组;两组结果差异具有统计学意义(P<0.05)。结论:采用低分子肝素联合常规治疗方式能够有效控制羊水过少的发展,提高患者的治疗效果,改善患者的临床症状,降低不良并发症的发生,值得在临床上推广使用。
Objective: Low molecular weight heparin on the treatment of oligohydramnios, to explore the efficacy and clinical application of adaptability. Methods: 100 cases of pregnant women with oligohydramnios received in our hospital from January 2016 to February 2017 were selected as the research object, and were divided into control group and experimental group according to the order of admission of pregnant women, Each group contains 50 cases of pregnancy patients. Patients in the control group were treated with glucose instillation according to the development of the disease and the patient’s constitution. The experimental group was treated with low molecular weight heparin on the basis of the treatment of the control group, and the treatment effect was recorded and compared between the two groups. Results: The cure rate of the experimental group was significantly higher than that of the control group. The amniotic fluid index and umbilical artery blood flow resistance of the experimental group were significantly better than those of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Low molecular weight heparin combined with conventional treatment can effectively control the development of oligohydramnios, improve the therapeutic effect of patients, improve the clinical symptoms of patients and reduce the incidence of adverse complications, which is worth popularizing in clinic.